Lv4
466 积分 2021-11-06 加入
Utilization of weight management treatment and subsequent cardiovascular events among patients with breast cancer
8天前
已完结
Exploring the potential impact of GLP-1 receptor agonists in cancer therapy
8天前
已完结
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
16天前
已完结
The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study
17天前
已完结
Phase separation of DDHD2 remodels lipid metabolism to dictate treatment sensitivity in luminal breast cancer
1个月前
已完结
Survival Outcomes With or Without Risk-Reducing Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers
1个月前
已完结
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
2个月前
已完结
Guanosine diphosphate–mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer
3个月前
已完结
Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor
3个月前
已完结
Pathologic complete response (pCR) rates for patients with HR+/HER2− high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial
3个月前
已完结
皖公网安备34019202002308
